Common Name |
Pemirolast
Description |
Pemirolast potassium is a slightly yellow powder that is soluble in water. It is a mast cell stabilizer that acts as an antiallergic agent. As an ophthalmic aqueous sterile solution, pemirolast is used for the prevention of itching of the eyes caused by allergies such as hay fever, and allergic conjunctivitis. Pemirolast is potentially usefli for prophylaxis of plimonary hypersensitivity reactions to drugs such as paclitaxel.
Structure |
MOLSDF3D-SDFPDBSMILESInChI View 3D Structure
Synonyms |
Value |
Source |
PemiroxKegg
Pemirolast potassiumHMDB
Pemiroplast potassiumHMDB
Pemirolast potassium saltMeSH
AlamastMeSH
9-TBXMeSH
9-Methyl-3-(1H-tetrazol-5-yl)-4H-pyrido(1,2-a)pyrimidin-4-oneMeSH
Chemical Formlia |
C10H8N6O
Average Molecliar Weight |
228.2101
Monoisotopic Molecliar Weight |
228.075958908
IUPAC Name |
9-methyl-3-(2H-1,2,3,4-tetrazol-5-yl)-4H-pyrido[1,2-a]pyrimidin-4-one
Traditional Name |
pemirolast
CAS Registry Number |
100299-08-9
SMILES |
CC1=CC=CN2C(=O)C(=CN=C12)C1=NNN=N1
InChI Identifier |
InChI=1S/C10H8N6O/c1-6-3-2-4-16-9(6)11-5-7(10(16)17)8-12-14-15-13-8/h2-5H,1H3,(H,12,13,14,15)
InChI Key |
HIANJWSAHKJQTH-UHFFFAOYSA-N
Chemical Taxonomy |
Description |
This compound belongs to the class of chemical entities known as pyridopyrimidines. These are compounds containing a pyridopyrimidine, which consists of a pyridine fused to a pyrimidine. Pyridine is 6-membered ring consisting of five carbon atoms and a nitrogen atom. Pyrimidine is a 6-membered ring consisting of four carbon atoms and two nitrogen centers at the 1- and 3- ring positions.
Kingdom |
Chemical entities
Super Class |
Organic compounds
Class |
Organoheterocyclic compounds
Sub Class |
Pyridopyrimidines
Direct Parent |
Pyridopyrimidines
Alternative Parents |
Pyrimidones
Methylpyridines
Tetrazoles
Heteroaromatic compounds
Lactams
Azacyclic compounds
Organopnictogen compounds
Organooxygen compounds
Organonitrogen compounds
Organic oxides
Hydrocarbon derivatives
Substituents |
Pyridopyrimidine
Pyrimidone
Methylpyridine
Pyridine
Pyrimidine
Azole
Tetrazole
Heteroaromatic compound
Lactam
Azacycle
Organic oxide
Organopnictogen compound
Organic oxygen compound
Organic nitrogen compound
Organooxygen compound
Organonitrogen compound
Hydrocarbon derivative
Aromatic heteropolycyclic compound
Molecliar Framework |
Aromatic heteropolycyclic compounds
External Descriptors |
Not Available
Ontology |
Status |
Expected but not Quantified
Origin |
Drug
Biofunction |
Anti-Allergic Agents
Antipruritics
Histamine Antagonists
Ophthalmics
Application |
Pharmaceutical
Cellliar locations |
Membrane
Physical Properties |
State |
Solid
Experimental Properties |
Property |
Value |
Reference |
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water Solubility4.62e-01 g/LNot Available
LogP0Not Available
Predicted Properties |
Property |
Value |
Source |
Water Solubility0.46 mg/mLALOGPS
logP0.13ALOGPS
logP1.46ChemAxon
logS-2.7ALOGPS
pKa (Strongest Acidic)5.8ChemAxon
pKa (Strongest Basic)-1.4ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count5ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area87.13 Å2ChemAxon
Rotatable Bond Count1ChemAxon
Refractivity63.35 m3·mol-1ChemAxon
Polarizability21.96 Å3ChemAxon
Number of Rings3ChemAxon
Bioavailability1ChemAxon
Rlie of FiveYesChemAxon
Ghose FilterYesChemAxon
Vebers RlieYesChemAxon
MDDR-like RlieYesChemAxon
Spectra |
Spectra |
Not Available
Biological Properties |
Cellliar Locations |
Membrane
Biofluid Locations |
Blood
Urine
Tissue Location |
Not Available
Pathways |
Not Available
Normal Concentrations |
Biofluid |
Status |
Age |
Condition |
Reference |
Details |
BloodExpected but not Quantified Not AvailableNot AvailableTaking drug identified by DrugBank entry DB00885
21059682
details
UrineExpected but not Quantified Not AvailableNot AvailableTaking drug identified by DrugBank entry DB00885
21059682
details
|
Abnormal Concentrations |
|
Not Available
Associated Disorders and Diseases |
Disease References |
None
Associated OMIM IDs |
None
External Links |
DrugBank ID |
DB00885
DrugBank Metabolite ID |
Not Available
Phenol Explorer Compound ID |
Not Available
Phenol Explorer Metabolite ID |
Not Available
FoodDB ID |
Not Available
KNApSAcK ID |
Not Available
Chemspider ID |
51990
KEGG Compound ID |
Not Available
BioCyc ID |
Not Available
BiGG ID |
Not Available
Wikipedia Link |
Not Available
NuGOwiki Link |
HMDB15023
Metagene Link |
HMDB15023
METLIN ID |
Not Available
PubChem Compound |
57697
PDB ID |
Not Available
ChEBI ID |
775149
Product: AMG 838 (calcium hydrate)
References |
Synthesis Reference |
Not Available |
Material Safety Data Sheet (MSDS) |
Not Available |
General References |
- Tinkelman DG, Berkowitz RB: A pilot study of pemirolast in patients with seasonal allergic rhinitis. Ann Allergy. 1991 Feb;66(2):162-5. [PubMed:1994787 ]
|
Enzymes
- General function:
- Involved in G-protein coupled receptor protein signaling pathway
- Specific function:
- In peripheral tissues, the H1 subclass of histamine receptors mediates the contraction of smooth muscles, increase in capillary permeability due to contraction of terminal venules, and catecholamine release from adrenal medulla, as well as mediating neurotransmission in the central nervous system
- Gene Name:
- HRH1
- Uniprot ID:
- P35367
- Molecular weight:
- 55783.6
References
- Yanni JM, Miller ST, Gamache DA, Spellman JM, Xu S, Sharif NA: Comparative effects of topical ocular anti-allergy drugs on human conjunctival mast cells. Ann Allergy Asthma Immunol. 1997 Dec;79(6):541-5. [PubMed:9433371 ]
- Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. [PubMed:11752352 ]
- Kobayashi K, Hiroi J, Kishi S, Sawase K, Hirayama Y, Chihara S, Imai T, Shigi Y, Shimomura K, Kohsaka M: Effects of quinotolast, a new orally active antiallergic drug, on experimental allergic models. Jpn J Pharmacol. 1993 Sep;63(1):73-81. [PubMed:7505860 ]
PMID: 7831317